News
Nanophase Technologies Announces Q2 2024 Financial Release and Conference Call Details
Nanophase Technologies Corporation
Romeoville, Illinois, July 29, 2024 (GLOBE NEWSWIRE) — Nanophase Technologies Corporation (OTCQB: NANX), a leader in scientifically driven, mineral-based health solutions in the beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced that the company will release its second-quarter 2024 financial report after the market closes on Tuesday, August 6, 2024, with an investor conference call to follow on Wednesday, August 7.
Second Quarter 2024 Conference call
Nanophase will hold its second quarter conference call on Wednesday, August 7, 2024, at 11:00 a.m. CDT, 12:00 p.m. EDT, to discuss its financial results and provide a business and financial update. Joining the call will be Jess Jankowski, the Company’s President and Chief Executive Officer, joined by Kevin Cureton, the Company’s Chief Operating Officer.
Participant Registration:
https://register.vevent.com/register/BI1f3051f859dd4b0e901722ef14e8ee82
To receive the dial-in number as well as your personalized PIN, you must register at the link above. Once registered, you will also have the option to have the system dial you in once the conference call has begun. If you forget your PIN before the conference call, you can simply register again.
Webcast and listen-only replay:
https://edge.media-server.com/mmc/p/58zb87un
The call can also be accessed through the company’s website at www.nanophase.com by clicking on Investor Relations, Investor News and the links in this conference call announcement release. Please connect to the conference at least five minutes prior to the scheduled start time.
About NanophasIt is
Nanophase Technologies Corporation (OTCQB: NANX), www.nanophase.comis a leading innovator of scientifically driven, mineral-based health solutions in beauty and life science categories, as well as other legacy advanced materials applications. Leveraging a platform of integrated, patented and proprietary technologies, the company creates uniquely performing products that improve the health and well-being of consumers. We deliver commercial-grade, engineered materials both as ingredients and as part of fully formulated products in a variety of formats.
###
Investor Relations Contact:
Phone: (630) 771-6736